Results 181 to 190 of about 715,175 (219)

Anticholinergic Drug Burden and Delirium: A Systematic Review [PDF]

Journal of the American Medical Directors Association, 2021
To investigate the association between anticholinergic drug burden (ADB), measured with anticholinergic drug scales, and delirium and delirium severity.Systematic review.All available studies.A systematic literature search was performed in Medline, Embase, PsycINFO, Web of Science, CINAHL, Cochrane library, and Google Scholar.
Francesco U S Mattace-Raso, Angelique Egberts, Gijsbertus Ziere   +2 more
exaly   +4 more sources

Evaluation of the association of anticholinergic burden and delirium in older hospitalised patients – A cohort study comparing 19 anticholinergic burden scales

British Journal of Clinical Pharmacology, 2022
AimsA recent review identified 19 anticholinergic burden scales (ABSs) but no study has yet compared the impact of all 19 ABSs on delirium. We evaluated whether a high anticholinergic burden as classified by each ABS is associated with incident delirium.MethodWe performed a retrospective cohort study in a Swiss tertiary teaching hospital using data ...
Monika Lutters, Angela Lisibach, Chantal Csajka   +2 more
exaly   +5 more sources

Association between anticholinergic burden and anticholinergic adverse outcomes in the elderly: Pharmacological basis of their predictive value for adverse outcomes

Pharmacological Research, 2021
The use of anticholinergic drugs and other drugs with anticholinergic activity is highly prevalent in older people. Cumulative anticholinergic effects, known as anticholinergic burden, are associated with important peripheral and central adverse effects ...
Ana C Cabral, Manuel T. Veríssimo, Margarida Castel-Branco   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Anticholinergic burden in Parkinson’s disease inpatients

European Journal of Clinical Pharmacology, 2015
Anticholinergic toxicity can arise as a result of the cumulative burden of multiple medications and metabolites rather than be caused by a single compound. In this sense, prescribing drugs with anticholinergic properties to Parkinson's disease (PD) patients could contribute to aggravate some frequent problems of the disease, like dementia, urinary ...
Unax, Lertxundi, Arantxazu, Isla, Maria Angeles, Solinis, Saioa, Domingo-Echaburu, Rafael, Hernandez, Javier, Peral-Aguirregoitia, Juan, Medrano   +6 more
openaire   +2 more sources

Evaluation of anticholinergic burden of medications in older adults

Journal of the American Pharmacists Association: JAPhA, 2013
To calculate and describe the anticholinergic burden of medications in community-dwelling older adults and to identify patient-specific risk factors.Descriptive cross-sectional study.Cardinal Health Visiting Pharmacist Program, Columbus, OH, between August 2002 and August 2009.Community-dwelling adults 65 years or older who were referred through ...
Kyle Porter
exaly   +3 more sources

Cognitive burden of anticholinergic medications in psychotic disorders [PDF]

Schizophrenia Research, 2017
Patients with psychotic disorders are often treated with numerous medications, many of which have anticholinergic activity. We assessed cognition in relation to the cumulative anticholinergic burden of multiple drugs included in treatment regimens of participants from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study ...
Jeffrey R Bishop, Richard S E Keefe, Sarah Keedy   +2 more
exaly   +3 more sources

Anticholinergic Burden and Xerostomia in Critical Care Settings

Dimensions of Critical Care Nursing, 2023
Background Although previous studies have established the association of medications with anticholinergic adverse effects and xerostomia, anticholinergic burden and xerostomia in critical care settings are poorly characterized.
Joohyun, Chung, Jennifer, Tjia, Ning, Zhang, Brendan T, O'Connor   +3 more
openaire   +2 more sources

Atropinic (Anticholinergic) Burden in Parkinson's Disease

Movement Disorders, 2016
AbstractUse of atropinic drugs remains controversial in Parkinson's disease (PD) because there is insufficient evidence about their efficacy and they can induce serious adverse drug reactions. Atropinic risk scales were developed to help to identify atropinic drugs in prescription forms and to evaluate their burden in clinical practice.
Sibylle, De Germay, Jean-Louis, Montastruc, Vanessa, Rousseau, Leila, Chebane, Emmanuelle, Bondon-Guitton, Florence, Moulis, Genevieve, Durrieu, Haleh, Bagheri, Olivier, Rascol, Antoine, Pariente, Bernard, Bégaud, François, Montastruc   +11 more
openaire   +2 more sources

Anticholinergic Burden in Hospice Patients With Dementia

American Journal of Hospice and Palliative Medicine®, 2018
Background: End-of-life (EOL) patients with dementia have an increased risk for anticholinergic toxicities due to age-related pharmacokinetic and physiologic changes in conjunction with an increased susceptibility to drug-induced cognitive impairments.
Anne Williams, Leah Sera, Mary Lynn McPherson   +2 more
openaire   +2 more sources

Anticholinergic Burden and Cognitive Impairment in Nursing Homes: A Comparison of Four Anticholinergic Scales

Drugs & Aging, 2023
Medications with anticholinergic effects are commonly used in nursing homes, and their cumulative effect is of particular concern for the risk of adverse effects on cognition.The relation between cognitive function and anticholinergic burden measured with four scales, the Anticholinergic Cognitive Burden (ACB) Scale, the Anticholinergic Risk Scale, the
Alessio Novella, Chiara Elli, Aladar Ianes, Luca Pasina   +3 more
openaire   +2 more sources